News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Chad Therapeutics, Inc. (CTU) Closes Sale of Transfilling Assets for $1.825 Million in Cash


3/7/2008 9:30:12 AM

CHATSWORTH, Calif.--(BUSINESS WIRE)--CHAD Therapeutics, Inc. (AMEX:CTU) announced today that it has closed the sale of the assets related to its transfilling oxygen business for $1.825 million in cash, pursuant to an asset purchase agreement. As a result of the sale, CHAD will discontinue production and sales of its transfilling oxygen products.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES